77 reports

Antiviral Combination Therapies Market – Scope of the Report This report on the global antiviral combination therapies market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030.The report provides the...

  • Antiviral
  • World

Respiratory Antiviral Treatment Market – Scope of the Report This report on the global respiratory antiviral treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030.The report provides...

  • Antiviral
  • World

A recent market report published on the sterile and antiviral packaging market provides global industry analysis for 2015-2019 & forecast for 2020-2030. The report offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical, as well as current growth parameters of the sterile...

  • Antiviral
  • World

Respiratory Antiviral Treatment Market – Scope of the Report This report on the global respiratory antiviral treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030.The report provides...

  • Antiviral
  • World

Figure ##. Prominent Players in the Antiviral Drug Resistance Market

  • Antiviral
  • APAC
  • World
  • Europe
  • HIV AIDS Prevalence
  • HIV Incidence

Europe Antiviral Hepatitis Treatment Auto Aftermarket HIV Antiviral

  • Antiviral
  • Europe
  • Drug Approval
  • HIV AIDS Prevalence

APAC Antiviral Hepatitis Treatment Generic Drug Auto Aftermarket HIV Antiviral

  • Antiviral
  • APAC
  • Drug Approval
  • Foreign Direct Investment

Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Application (HIV, Hepatitis, Influenza), By Type (Branded, Generic), By Region, And Segment Forecasts, 2020 - 2027 The global antiviral drugs market size is expected to reach USD 46.9 billion by 2027. It is estimated to register a CAGR of...

  • Antiviral
  • HIV AIDS
  • World

Abstract: - Global Antivirals Drug Market to Reach $55.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Antivirals Drug estimated at US$46.3 Billion in the year 2020, is projected to reach a revised size of US$55.4 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027. Nucleotide...

  • Antiviral
  • World
  • China
  • United States

Abstract: - Global Antimicrobial Ingredients Market to Reach 94.1 Thousand Tons by 2027 - Amid the COVID-19 crisis, the global market for Antimicrobial Ingredients estimated at 78.2 Thousand Tons in the year 2020, is projected to reach a revised size of 94.1 Thousand Tons by 2027, growing at a CAGR of 2.7% over the...

  • Antifungal
  • Antiviral
  • Antiseptics
  • Anti-Infective
  • World
  • China
  • United States

Both the companies will jointly develop EIDD- ##, an orally available antiviral candidate which is currently in early clinical development for the treatment of patients with COVID-##.

  • Therapy
  • Antiviral
  • World
  • APAC
  • Health Expenditure
  • Gross Domestic Product Per Capita

Global Antiviral Drugs Market 2020-2024 The analyst has been monitoring the antiviral drugs market and it is poised to grow by $ 43.37 bn during 2020-2024 progressing at a CAGR of 9% during the forecast period. Our reports on antiviral drugs market provides a holistic analysis, market size and forecast, trends, growth...

  • Antiviral
  • World

Anti-Viral Therapies Market by Type (Generic Drugs and Branded Drugs), Application (HIV, Hepatitis, Herpes Virus, Influenza, and Other Applications), and Mechanism of Action (Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026 The...

  • Antiviral
  • World
  • APAC

Major players in the remdesivir market are Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer, Merck, Cayman Chemical, and Dr. Reddy’s Laboratories. Gilead’s antiviral remdesivir is being tested in multiple phase 3 clinical trials as a treatment for moderately and severely ill...

  • Infectious Disease
  • Clinical Trial
  • Antiviral
  • Research And Development
  • United States
  • World

Nanotechnology and nanomaterials can significantly address the many clinical and public healthcare challenges that have arisen from the coronavirus pandemic This analysis examines in detail how nanotechnology and nanomaterials can help in the fight against this pandemic disease, and ongoing mitigation strategies Nano-based products are currently...

  • Nanotechnology
  • Antiviral
  • Nanomaterial
  • Carbon Nanotube
  • Infectious Disease
  • Drug Delivery

When the current global crisis has abated, efforts must turn to future preventative measures Nanocoatings can demonstrate up to 99.9998% effectiveness against bacteria, formaldehyde, mold and viruses and are up to 1000 times more efficient than previous technologies available on the market They can work on multiple levels at the same time:...

  • Antiviral
  • Antiseptics
  • Antifungal
  • World

‘Hepatitis C Virus (HCV) - Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the HCV, historical and forecasted epidemiology as well as the HCV market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. The HCV market report provides current...

  • Hepatitis
  • Hepatitis Treatment
  • United States
  • Japan
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Use Of Prescription Drugs
  • Drug Approval

Single-Domain Antibody Platforms Market - Scope of Report A latest publication on the global single-domain antibody platforms market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global single-domain antibody platforms...

  • Antiviral
  • World

This study covers the world outlook for systemic antiviral pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Pharmaceutical
  • Antiviral
  • World
  • United States
  • Disposable Income
  • Gross Domestic Product

## Some Major Antiviral Compounds

  • Antiviral
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

##.## Global Entry Inhibitor Antiviral Market Forecast by Value

  • Hepatitis
  • Antiviral
  • World
  • Health Expenditure
  • Prescription Drug Sales

North America Liver Disease Treatment Market by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, and Chemotherapy) and Disease Type (Hepatitis, Autoimmune Diseases, Non-Alcoholic Fatty Liver Disease, Cancer, Genetic Disorders, and Others): Opportunity Analysis and Industry...

  • Digestive System Disorder
  • Antiviral
  • North America

Diagnostic testing, antiviral and antimicrobial coatings and surfaces, air-borne filtration, facemasks, PPE, drug delivery and therapeutics   Nanotechnology and nanomaterials can significantly address the many clinical and public healthcare challenges that have arisen from the coronavirus pandemic. This analysis...

  • Drug Delivery
  • Infectious Disease
  • Carbon Nanotube
  • Antiviral
  • United States

Report Scope: This report organizes information from diverse sources into sections, including an overview, industry structure, diagnostic test type, treatment by drug categories, leading drug profiles and historic drug sales, regulations, reimbursements and patents.The scope of this report includes an overview of the global...

  • HIV AIDS
  • HIV Antiviral
  • World
  • Drug Approval

Revenue Forecasts for Hepatitis C Therapeutics, Direct-Acting Antivirals, Ribavirin, Protease Inhibitors, Polymerase Inhibitors, Interferons & R&D Report Details How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this...

  • Hepatitis
  • Antiviral
  • World
  • Europe
  • Asia

This study covers the latent demand outlook for systemic antiviral pharmaceuticals across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city...

  • Pharmaceutical
  • Antiviral
  • India
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for systemic antiviral pharmaceuticals across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter...

  • Pharmaceutical
  • Antiviral
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for systemic antiviral pharmaceuticals across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the...

  • Pharmaceutical
  • Antiviral
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the world outlook for antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Antiviral
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for generic antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antiviral
  • World
  • Gross Domestic Product
  • Disposable Income